Annual report pursuant to Section 13 and 15(d)

Note 1 - Description of Business and Basis of Operation (Details Textual)

v3.3.1.900
Note 1 - Description of Business and Basis of Operation (Details Textual)
12 Months Ended
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Perma Fix of Medical Corporation [Member]    
Capital Investment in Publicly Traded Shell Company Percentage Acquired 60.50%  
Number of Reportable Segments 3  
Working Capital $ 3,091,000 $ 372,000
Working Capital, Increase from Prior Period 2,719,000  
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest $ (63,000) $ (2,992,000)